These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7804735)

  • 21. Laboratory markers of coagulation activation.
    Bauer KA
    Arch Pathol Lab Med; 1993 Jan; 117(1):71-7. PubMed ID: 8418767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects.
    De CR; Rocca B; Marchioli R; Landolfi R
    Thromb Haemost; 2002 Jan; 87(1):58-67. PubMed ID: 11848457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential analytes for the diagnosis of thrombosis. An overview.
    Mann KG
    Ann Epidemiol; 1992 Jul; 2(4):365-70. PubMed ID: 1342287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current views of activating and regulatory mechanisms of blood coagulation].
    Osaki T; Ichinose A
    Nihon Rinsho; 2014 Jul; 72(7):1206-11. PubMed ID: 25163309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
    Tripodi A; Primignani M; Lemma L; Chantarangkul V; Mannucci PM
    J Hepatol; 2013 Aug; 59(2):265-70. PubMed ID: 23583273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.
    Dahlbäck B
    J Intern Med; 2005 Mar; 257(3):209-23. PubMed ID: 15715678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection and inflammation as risk factors for thrombosis and atherosclerosis.
    Levi M; van der Poll T; Schultz M
    Semin Thromb Hemost; 2012 Jul; 38(5):506-14. PubMed ID: 22399308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Markers of intravascular activation of coagulation].
    Zawilska K
    Acta Haematol Pol; 1994; 25(2 Suppl 2):27-33. PubMed ID: 7998471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation markers of coagulation.
    Bauer KA; Rosenberg RD
    Baillieres Clin Haematol; 1994 Sep; 7(3):523-40. PubMed ID: 7841599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the coagulation profile in children with liver disease and extrahepatic portal vein obstruction or shunt.
    Beattie W; Magnusson M; Hardikar W; Monagle P; Ignjatovic V
    Pediatr Hematol Oncol; 2017 Mar; 34(2):107-119. PubMed ID: 28570120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
    Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New markers for in vivo coagulation.
    Bauer KA
    Curr Opin Hematol; 1994 Sep; 1(5):341-6. PubMed ID: 9371303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The endothelium as the central control site of the coagulation cascade].
    Nawroth PP; Stern DM
    Z Kardiol; 1989; 78 Suppl 6():16-24. PubMed ID: 2694663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.
    Kuo KH; Khan S; Rand ML; Mian HS; Brnjac E; Sandercock LE; Akula I; Julien JP; Pai EF; Chesney AE
    PLoS One; 2016; 11(3):e0149830. PubMed ID: 26934472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into platelet-based control of coagulation.
    de Witt SM; Verdoold R; Cosemans JM; Heemskerk JW
    Thromb Res; 2014 May; 133 Suppl 2():S139-48. PubMed ID: 24862135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombogenic mechanisms in the human: fresh insights obtained by immunodiagnostic studies of coagulation markers.
    Boisclair MD; Philippou H; Lane DA
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1007-21. PubMed ID: 8148474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipoproteins, hemostasis and thrombosis.
    Griffin JH; Fernández JA; Deguchi H
    Thromb Haemost; 2001 Jul; 86(1):386-94. PubMed ID: 11487028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel peptides that inhibit heparanase activation of the coagulation system.
    Axelman E; Henig I; Crispel Y; Attias J; Li JP; Brenner B; Vlodavsky I; Nadir Y
    Thromb Haemost; 2014 Sep; 112(3):466-77. PubMed ID: 25030319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.